Vimarsana
Biggest News Aggregation in the World

Page 9 - Trevena News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trevena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trevena Today - Breaking & Trending Today

Trevena, Inc. (NASDAQ:TRVN) Short Interest Update - Vimarsana News

Trevena, Inc. (NASDAQ:TRVN) Short Interest Update

Trevena, Inc. (NASDAQ:TRVN – Get Rating) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 53,400 shares, a drop of 57.2% from the March 15th total of 124,900 shares. Based on an average daily trading volume, of 104,200 shares, the short-interest ratio is currently 0.5 days. […]

Trevena (NASDAQ:TRVN) Stock Rating Upgraded by StockNews.com - Vimarsana News

Trevena (NASDAQ:TRVN) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Trevena (NASDAQ:TRVN – Get Rating) to a sell rating in a research report sent to investors on Tuesday morning. Several other brokerages have also issued reports on TRVN. HC Wainwright decreased their price target on shares of Trevena from $11.00 to $9.00 and set a buy rating for the company in […]

Source: wkrb13.com
Trevena (NASDAQ:TRVN) Upgraded to "Sell" at StockNews.com - Vimarsana News

Trevena (NASDAQ:TRVN) Upgraded to "Sell" at StockNews.com

Trevena (NASDAQ:TRVN – Get Rating) was upgraded by research analysts at StockNews.com to a “sell” rating in a report released on Tuesday. Other equities analysts also recently issued reports about the company. JMP Securities restated a “market outperform” rating and set a $2.00 price objective on shares of Trevena in a research report on Friday. […]

JMP Securities Reiterates Market Outperform Rating for Trevena (NASDAQ:TRVN) - Vimarsana News

JMP Securities Reiterates Market Outperform Rating for Trevena (NASDAQ:TRVN)

JMP Securities reaffirmed their market outperform rating on shares of Trevena (NASDAQ:TRVN – Get Rating) in a report published on Friday morning, Benzinga reports. JMP Securities currently has a $2.00 target price on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the stock. StockNews.com began coverage on shares […]

Head-To-Head Analysis: Trevena (NASDAQ:TRVN) and Merck & Co., Inc. (NYSE:MRK) - Vimarsana News

Head-To-Head Analysis: Trevena (NASDAQ:TRVN) and Merck & Co., Inc. (NYSE:MRK)

Trevena (NASDAQ:TRVN – Get Rating) and Merck & Co., Inc. (NYSE:MRK – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability. Insider and Institutional Ownership 72.9% of Merck & Co., […]